http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105616346-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 |
| filingDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105616346-B |
| titleOfInvention | A kind of pharmaceutical composition of Edaravone and preparation method thereof |
| abstract | The invention belongs to pharmaceutical technology fields, specifically, it is related to a kind of pharmaceutical composition of Edaravone, wherein, the pharmaceutical composition is water for injection injection, and composition includes: Edaravone 1.5mg/mL, 0.5~1.0mg/mL of tea polyphenols, 1.0~2.0mg/mL of vitamin C, 0.07~0.2mL/mL of propylene glycol.Edaravone and tea polyphenols play synergistic effect in pharmaceutical composition of the invention, enhance the ability that Edaravone removes free radical, improve its protective effect to cranial nerve, while possessing good stability. |
| priorityDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.